News & Events
RGCC participates in landmark conference marking the launch of the International Society for Personalized Metabolic Oncology (ISPMO) in Kuala Lumpur
Kuala Lumpur, Malaysia
RGCC was honored to take part in a significant international conference in Kuala Lumpur, which marked the official launch…
RGCC International Announces the Launch of InVyomma Plus: A Revolutionary Gut Microbiome Profiling Test
RGCC International is proud to announce the launch of its latest test, InVyomma Plus. The test is designed to…
RGCC International at DMCCB Basel Symposium 2025: Celebrating Excellence in Cancer Research
RGCC International is honored to have participated in the DMCCB Basel Symposium 2025.
As part of its Corporate Social Responsibility activities, RGCC International Donates CHF 15,000 to Universitäts-Kinderspital Zürich
As part of its ongoing commitment to Corporate Social Responsibility (CSR), RGCC International is proud to announce a donation…
RGCC and PERABOI Sign MOU for a Clinical Study on Circulating Tumor Cells in Breast Cancer
October 4th, 2024 – Bali, Indonesia: RGCC, a leader in advanced diagnostic technologies, and the Indonesian Association of Surgical…
RGCC Participates in Indonesia International Cancer Conference
Bali, Indonesia
RGCC is proud to have participated in the Indonesia International Cancer Conference (IICC) held from 3-5 October 2024
RGCC North America Gathering 2024: Advancing Cancer Care Through Collaboration and Innovation
Denver, Colorado
The RGCC North America Gathering 2024 took place from 17-19 October 2024 at the Denver Marriott Tech Center, bringing…
Applications now open for the Cancer Drug Discovery Research Award
The Cancer Drug Discovery Research Award, supported by RGCC International and The Swiss Chemical Society is here to honor…
RGCC SA laboratory in Greece receives prestigious certification from Japan’s Ministry Of Health, Labour and Welfare
Japan
RGCC SA is proud to announce that our state-of-the-art laboratory in Greece has been awarded the accreditation certificate of…
RGCC Unveils Revolutionary Cancer Detection Test, Onco-D-clare
RGCC announces the launch of Onco-D-clare, a groundbreaking cancer detection test that marks a significant milestone in early cancer…
Top 10 Swiss Biotech Company 2023
We are delighted to announce that RGCC has received prestigious recognition as one of the top 10 Swiss Biotech…
Recap: RGCC Malaysia Conference 2024 - Advancing Cancer Care in Southeast Asia
Kuala Lumpur, Malaysia
In March 2024, RGCC, in collaboration with SOL Integrative Wellness Centre, hosted its inaugural Malaysia Conference in Kuala Lumpur,…